Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2011 - 2026)

Rigel Pharmaceuticals' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.59 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 50.72% year-over-year to 0.59; the TTM figure through Mar 2026 stood at 0.59 (down 50.72% YoY), while the FY2025 annual figure was 0.87, down 31.88% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.59, down from 0.78 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 1.4 in Q2 2025, with the low at 0.54 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 1.01 (2023), against an average of 0.98.
• The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio soared 87.13% in 2023, then tumbled 50.72% in 2026.
• Rigel Pharmaceuticals' Asset Utilization Ratio stood at 0.96 in 2022, then gained by 4.45% to 1.01 in 2023, then grew by 17.57% to 1.18 in 2024, then sank by 34.14% to 0.78 in 2025, then decreased by 24.35% to 0.59 in 2026.
• Business Quant data shows RIGL's Asset Utilization Ratio at 0.59 in Q1 2026, 0.78 in Q4 2025, and 1.26 in Q3 2025.